IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q4 2019 Holdings

Filed 2020-02-18 | 12 holdings | $32.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$32.6M109,90499.2%
United Therapeutics Corp(UTHR)COM91307C102$40.6K460,9440.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$39.2K104,4200.1%
Mckesson Corp(MCK)COM58155Q103$35.2K254,3300.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$33.9K313,5560.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$30.2K489,3850.1%
Taro Pharmaceutical IndusCOMM8737E108$29.9K339,8190.1%
Alkermes PLC(ALKS)COMG01767105$18.5K905,0780.1%
RTI Surgical HDS IncCOM74975N105$9.9K3,628,9630.0%
Invacare CorpCOM461203101$7.9K880,4020.0%
Gilead Sciences Inc(GILD)COM375558103$7.9K121,8610.0%
Anaptysbio Inc(ANAB)COM032724106$7.2K440,4090.0%